By Iain Gilbert
Date: Thursday 15 Jan 2026
(Sharecast News) - Manufacturing and research company Oxford Instruments reaffirmed its full‑year guidance on Thursday, with adjusted operating profits expected to be in line with market forecasts of £70.2m to £73.0m.
| Form 8.3 - NCC Group plc | 15-Jan-2026 | 15:20 | RNS |
| Form 8.3 - Oxford Biomedica plc | 15-Jan-2026 | 15:20 | RNS |
| Form 8.3 - Oxford Biomedica plc | 15-Jan-2026 | 15:17 | RNS |
| Form 8.3 - The Vanguard Group, Inc.: NCC Group plc | 15-Jan-2026 | 14:40 | EQS Group |
| Form 8.3 - The Vanguard Group, Inc.: Oxford Biom... | 15-Jan-2026 | 14:39 | EQS Group |
| Questor:Meggitt | 23-Dec-2014 | Telegraph |
| Questor :Ricardo | 31-Oct-2014 | Telegraph |
| Questor:CSR | 17-Oct-2014 | Telegraph |
| Questor:BAE Systems | 03-Sep-2014 | Telegraph |
| Questor :Sage Group | 09-May-2014 | Telegraph |
| Price | 8,612.41 |
| Change Today | 189.15 |
| % Change | 2.25 % |
| 14-Jan-26 Close | 8,423.26 |
You are here: research